chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient received an expired vaccine of 16-Apr-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient received an expired vaccine of 16-Apr-2022) in a 45-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 007J21-2a) for COVID-19 vaccination.     Patient did not have allergies to medications, food, and other products. Patient had no acute or chronic illnesses at the time of vaccination.     On 22-Apr-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 22-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient received an expired vaccine of 16-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient received an expired vaccine of 16-Apr-2022) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   The patient never ever had COVID positive test or diagnosis. The patient did not take other vaccines within 1 month prior to Moderna COVID-19 vaccine.  No concomitant medications were reported. It was reported that a total of 26 patients received an expired vaccine of 16-Apr-2022. It was unknown if patient had to seek medical care office visit, urgent care, ER or hospitalization. It was unknown if patient had similar experience in the past. No treatment medications were reported.
Severe headache; Chills; Muscle aches; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 14Apr2021 at 09:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. On 15Apr2021 at 05:00, the patient experienced severe headache, chills and muscle aches. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment with extra-strength acetaminophen (TYNELOL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe headache, chills and muscle aches was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
This case was reported by a consumer (the subject's mother) and described the occurrence of vomiting in a 9-month-old female subject who was vaccinated with DTAP vaccine (manufacturer unspecified). A physician or other health care professional has not verified this report. The subject's medical history included vomiting following previous unspecified vaccinations. Concurrent medical conditions included allergy to animal proteins and gelatin. Concurrent vaccination included three to four unspecified vaccines (unknown vaccines, manufacturers unspecified) given the same day as DTAP vaccine. Concurrent medications included Zantac. On an unspecified date the subject received 1st dose of DTAP vaccine (unknown route, unknown thigh) Forty-eight hours after vaccination with DTAP vaccine, the subject experienced vomiting. The subject vomited for 48 hours. The subject was hospitalised for 8 days. The mother reported that the subject "almost died". It took 3 to 4 days for the subject to get back to normal and 7 days total until she could eat. The subject was treated with pedialyte before going back onto food. The subject was also diagnosed with methemoglobinemia. The mother noted that the subject had been "severely" ill since infancy. At the time of reporting the vomiting was resolved and the outcome of the methemoglobinemia was unspecified. The mother noted that all the vaccines administered contained gelatin, and had delayed taking her daughter to the doctor to receive the next dose of vaccine for fear of her getting sick again. She reported that she intended to make sure that the subject was only given one vaccine at a time and that it dose not contain gelatin.
body aches; chills; low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body aches), CHILLS (chills) and PYREXIA (low grade fever) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL/HCTZ) for Hypertension.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (body aches), CHILLS (chills) and PYREXIA (low grade fever). At the time of the report, MYALGIA (body aches), CHILLS (chills) and PYREXIA (low grade fever) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment of these events were not provided.   This case was linked to MOD-2021-021849 (Patient Link).
1)  diagnosed with covid less than 4 weeks following injection  (same as last booster in Fall of 2021!!!! 2)  Blood pressure spike since vaccine and Dx of Covid  (I already take 2 BP meds and BP today at Clinic was 149/98!!! 3)  Ongoing headache - but didn't start until 2 weeks after vaccine - pretty sure it is relaed to the increased BP.
I received the Johnson and Johnson vaccine (1 shot) on April 1, 2021.  I felt fine for a week.  A week after the shot I feel ill with a high fever, aches, and fatigue (general flu-like symptoms).   I recovered, then a week later I suffered the same set back.  I went to get a Covid test and it was negative.  This past week I tried to resume general exercise, and I feel ill again.  At this point, when I attempt to do anything physical (not overly strenuous, but light exercise) I relapse into flu-like symptoms.  I am worried that I will continue to get flu-like symptoms when I try to exercise at all.  I am not sure how long to remain completely at rest.  It seems like 21 days should be enough.  I am confused on what to do and if this fatigue and flu symptoms will continue when I try any physical activity.
4 days p/vax pt was witnessed by mom to have a sz on rt side;sz lasted for 30-35 seconds;pt then seen @ clinic & found nl; p/multiple episodes pt was adm to hosp;
This is a spontaneous report from a contactable pharmacist, calling on behalf of a physician. The pharmacist stated that a male patient of unspecified age and ethnicity received, on 13JAN2015, PREVNAR13 single dose. No vaccines were given on the same date along with suspect vaccine and no vaccine were given within 4 weeks prior to PREVNAR13. Relevant medical history and concomitant medications were unknown. After the injection, on 13JAN2015, the patient experienced arm pain. At time of this report, the patient did not recover from the event.
An hour or two after my first Covid-19 Pfizer vaccine, I noticed a depression/dent in my arm at the injection site. At first I thought the Band-Aid was just pulled very tight, but upon removal I realized there was a fairly large (nickel-quarter sized) dimple/depression in my arm that had not been there before. It is still there to date.
Pain at injection site; This case was reported by a consumer and described the occurrence of injection site pain in a 61-year-old male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was not recovered/not resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingles vaccine.     Additional Information: GSK receipt date: 20-JAN-2023 Reporter's comment: This report was submitted by public reporting reference via the online reporting system. The patient had asked that, what he could do for the pain (Pain at injection site). The patient had stated that the symptoms were not treated at the time of reporting. The reporter had denied to provide further contact details. Additional supportive information : The dosage text was mentioned as 2 which was not captured in the case and was mentioned into the narrative only.
The next morning I started with heat and redness in my face at 0650, hives then appeared a few minutes all over my body by 0715.  Itching burning. Took 25 mg Benadyrl
Booster administer at .25. Patient was monitored. No adverse reaction noted from administration of booster.
4 days after getting my Covid shot, I started having large amounts of blood come out when I pooped. The second time was so much that I farted and blood covered the inside of the toilet bowl and it took me 8-10 times to wipe all the blood off my butt. I then continued to have it 3 additional times after (a total of 5 times). I went to my PCP and specifically asked if could be part of vaccine reaction. Was told no and sent to a specialist. Met with the specialist and was ordered a colonoscopy. I did the colonoscopy and there was absolutely nothing wrong. No evidence of any issues or irritants.
pt recvd vax & had splotchy swollen arm at inject site; devel diarrhea & itchy spots on neck  & back; also devel hives; 7pm everything nl;
expired dose was administered; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 73-year-old patient who received HAB (Twinrix) (batch number 4F3YY, expiry date 1st January 2023) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 4th January 2023, the patient received the 2nd dose of Twinrix and Twinrix Pre-Filled Syringe Device. On 4th January 2023, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 04-JAN-2023 Reporter's Comments: The reporter stated that a dose of Twinrix that expired on 1st January 2023, was administered to a patient. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up.  Additional Supportive Information: The patient received an expired dose of Twinrix, which led to expired vaccine used.
About 10 minutes after injection patient became dizzy, diaphoresis, flushed, hypotensive (100/80), drowsy, nausea. Patient was seated and legs elevated.  Cool water bottle placed behind neck, blood pressure obtained.  She remained in this positi9on for about 15 minutes.  No reaction noted at the injection site.  When she began to stabilize we offered juice which she took and began to feel better.  She was released to go home.  I contacted her mother at about 7:30pm that evening and patient was feeling much better
congestive heart failure; renal failure; lung problems; Information has been received regarding a case in litigation from an attorney concerning a female patient of unknown age. The patient's pertinent medical history, concurrent conditions or concomitant medications were not provided. On unspecified date, the patient received a dose of Zoster Vaccine Live (ZOSTAVAX) (lot #, expiration date, route of administration, dosage, and anatomical location were not provided) for prevention of shingles. After receiving the dose of Zoster Vaccine Live (ZOSTAVAX), the patient suffered congestive heart failure, lung problems and renal failure. As a result of these symptoms, the patient was seen and treated by the medical provider and was still under their care. As a direct and proximate result of vaccination, the patient's symptoms have resulted in physical limitations not present prior the use of this vaccine, and the patient sustained severe and permanent personal and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. At the time of the report, the reporter considered the events to be related to Zoster Vaccine Live (ZOSTAVAX). The patient had not recovered from the events, and the author considered the events to be disabling.  Upon internal review cardiac failure congestive and renal failure were considered medically significant.
Information has been received from a physician concerning a 12 year old female who on 14-APR-2008 was vaccinated with a third dose of GARDSIL (lot 3 not reported). Dates and lots of the previous two vaccinations were not reported. The physician reported that the patient's "parent phoned the office on 15 or 16- APR-2008 to state the patient had experienced a rash at injection site." The patient sought unspecified medical attention during the phone call. A the of this report the patient had not recovered from the rash. Additional information has been requested.  1/5/10 follow up - injection site rash: Urticaria initial  and follow up information has been received from a physician concerning a 12 yr old female student with seasonal allergies who on  16-apr-2008 (previously reported on 14-apr-2008) was vaccinated intramuscularly inton the right arm with a third dose of HPV 6 11 16 18 VLP vaccine. dates and lots of the previous two vaccinations were not reported. the physician reported that the patient's  parent phoned the office on 15 or 16 apr 2008 to state that the patient had experienced a  rash at the injection site. the patient sought unspecified medical attention.
This case was reported by a nurse via sales rep and described the occurrence of injury in a male healthcare professional with ROTARIX (batch number A41CB558A, expiry date unknown). On an unknown date, the patient received ROTARIX. On an unknown date, immediately after receiving ROTARIX, the patient experienced injury, inadvertent exposure to vaccine and pharmaceutical product complaint. On an unknown date, the outcome of the injury, inadvertent exposure to vaccine and pharmaceutical product complaint were unknown. It was unknown if the reporter considered the injury to be related to ROTARIX. Additional details were reported as follows: The age at vaccination was not applicable for this report. The vial cap of ROTARIX popped off which then broke and lead to cutting self (injury) and was exposed to vaccine which led to inadvertent exposure to vaccine. This was happened twice. It was reported that, the pressure related issue occurred more than once as the altitude was 5000 feet (exploding issues). No side effects were reported. The expiry date of vaccine and the date of birth of the patient were not reported. This case was one of the 4 cases reported by the same reporter.
Full body muscle cramps for the last two hours; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Full body muscle cramps for the last two hours) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (Full body muscle cramps for the last two hours). At the time of the report, MUSCLE SPASMS (Full body muscle cramps for the last two hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  Treatment information was not provided.   Reporter did not allow further contact
On 09/13/2005 mom reported that on 09/06/2005 while her child received shots. The vaccine from one shot squirted her,the mother, in the mouth. Exactly which vaccine is unknown but she received MMR, IPV and DTaP, she said single vaccine in Left arm. Reports she broke out in rash individual red spots started on 09/12 pm and increasing number 9/13/2005 spreading to arms and back. Referred her to her doctor.
HEADACHE; FEVER; MUSCLE ACHES; FATIGUE; NAUSEA; CHILLS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805022, and batch number: 1805022 expiry: UNKNOWN) .5 ml, administered on 06-MAR-2021 to Left Deltoid for prophylactic vaccination. No concomitant medications were reported. On 06-MAR-2021, the subject experienced headache. On 06-MAR-2021, the subject experienced fever. On 06-MAR-2021, the subject experienced muscle aches. On 06-MAR-2021, the subject experienced fatigue. On 06-MAR-2021, the subject experienced nausea. On 06-MAR-2021, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nausea, and chills on 06-MAR-2021, was recovering from headache, muscle aches, and fatigue, and had not recovered from fever. This report was non-serious.
pain in hip, neck, pain in her arm where the shot is and in the neck,; pain in armpit that is persistent; pain in hip, neck, pain in her arm where the shot is and in the neck,; pain in her arm where the shot is; Initial information was received on 25-Jul-2020 regarding an unsolicited valid non-serious case from a consumer/non-hcp.  This case involves a 36 year old female patient who experienced pain in her arm where the shot is and in the neck, pain in hip, neck and pain in armpit that is persistent (vaccination site pain, neck pain, axillary pain and arthralgia), while she received DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL].  Medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. At the time of the event, the patient had ongoing Food allergy (alpha-gal allergy).  On 26-Jul-2020, the patient received a 0.5 mL dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE lot number not reported (expiry date- 28-Jul-2020; Injection) via unknown route in the right arm for prophylactic vaccination.  On 26-Jul-2020, the patient developed a non-serious pain in her arm where the shot is and in the neck, pain in hip, neck and pain in armpit that is persistent (vaccination site pain, neck pain, axillary pain and arthralgia) on same day following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE.  Laboratory data was not provided.  Final diagnosis was vaccination site pain, neck pain, axillary pain and arthralgia.   Has not taken any medication for pain at this time.  The patient was not recovered from vaccination site pain, neck pain, axillary pain and arthralgia.  There will be no information available on the batch number for this case.
This case was reported by a other health professional and described the occurrence of incorrect storage of drug in a male patient who received BOOSTRIX (batch number 3P9CL, expiry date 15th April 2016). On an unknown date, the patient received BOOSTRIX. On an unknown date, an unknown time after receiving BOOSTRIX, the patient experienced incorrect storage of drug was unknown. Additional information: 3 patients vaccinated with vaccine that was stored at -2.56 C.
Donor described joint pain in upper body and muscle pain in shoulders, back, chest area, neck, general fatigue, mild headache for 4 days.
I got the shot about 1 pm, and everything went well. About 7 pm, my arm started to hurt, like every sore muscle. The pain grew, and my arm and shoulder hurt badly with any movement, so that when I used my arm, I cried out in pain. This morning the pain is there, and I wince with any movement, and if I forget and reach up, I cry out in pain. I know this is no big deal, but this was a very overt pain that I've not to experience in the past with shots I've received.
pt fainted was out no more than two min;fell on face bitting a large chunk out of lip & knocking two teeth loose;
presented to ER on 06/20/2008, admitted for vomiting x 3 days, was previously seen by primary doctor. admitted by our service for IV fluids, was found to have Intussusception via CT scan, had exploratory laparotomy with reduction of intussusceptum, appendectomy and small bowel obsruction.  7/8/08 Reviewed hospital medical records of 6/20-6/25/2008. FINAL DX: no d/c summary available.  Ileocolic intussusception, appendectomy & small bowel obstruction, exp laparotomy, small bowel resection per operative report. Records reveal patient experienced vomiting x 2.5 days, tiredness.  Taken to OR where IS was reduced & small bowel resection done due to ischemic gangrenous appearance.
2/22 Dizziness L arm tingling, feeling "weird." 2/23 L arm pain, stiff neck, chills, leg aches, swollen glands in L axilla, leg weakness. 3/4 herpes (oral), hip pain, joint pain, continued chills, light-headedness. Pt experienced a wide variety of symptoms over the first month after the injection (e.g. left upper leg rash, twitching/spasm in right hand, continued dizziness and chills, swollen glands in axilla, neck and groin, increased sensitivity to sensation over entire body, worsening fatigue that prevented normal activities of daily life and resulted in near immobilization, pain in veins of legs, joint inflammation and pain, low temperature, decreased appetite, peripheral numbness/tingling, "cracking" of joints). Saw her local MD, then moved out of town for assisted care. Saw Rheumatologist who stated it was serum sickness probably due to hep B vaccine. Was hospitalized on 4/26/02 for neurological testing: spinal tap, MRI, nerve conduction tests. Released after overnight stay, then readmitted for additional testing for 2 days. Returned home in early June 2002 and with daily PT, stretching and exercises, has been regaining some function and managing pain. Has been diagnosis of fibromyalgia, told not to have flu or hep B shots, and has returned to work part-time.
URI symptoms which started 2 or 3 days ago. Of concern is the fact that she lost her sense of taste and smell and she had a fever
pt recv vax & w/in 24 hr pt devel generalized hives & angioedema; pt was hospitalized & treated; pt recovered; No further clinical details provided;
mom of child states pt cried-screamed all evening-all noc p/1st inject; no comfort could quite pt down;
The patient received a second dose of Moderna at 22 days on October 20, 2022, instead of the scheduled 28 days; the first dose was given on September 29, 2022. We identified the error during an office visit. 4/6/2023
Received Varivax and Tdap in (L) arm yesterday. Small small amount of bruising last PM and awoke with red, tender area where received immunization (4.5x3cm). Rx Keflex today.
This is a spontaneous report from  a contactable consumer via Pfizer sales representative. A female patient of an unspecified age received TRUMENBA on an unspecified date at single dose for immunisation. Medical history was none. There were no concomitant medications.On an unknown date, after receiving the vaccine, the patient almost fainted. Outcome of the event was unknown. Information on the batch number has been requested.; Sender's Comments: Based on the information available, the Company cannot exclude that the suspect vaccine contributed to the development of the reported event "almost fainted".